(Q35783526)

English

An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells

scientific article published on 4 February 2012

Statements

An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells (English)
Andrew Stamm
Laura Valentine
Rashaun Potts
Mary Premenko-Lanier
4 February 2012
122-132

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit